Alternative Medicine

I read the letter to the editor of The Scientist about alternative medicine by Saul Green ( Feb. 19, 1996, page 11). I was surprised to see the comment, "When rigorous scientific trials on laetrile, vitamin C, hydrazine sulfate, chelation therapy, chiropractic, and homeopathy proved them worthless . . ." While I recognize that some of the trials to which he refers fail to demonstrate significant scientific evidence to support the use of a particular approach, that cannot be stated about the app

Written byJames Winterstein
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I read the letter to the editor of The Scientist about alternative medicine by Saul Green ( Feb. 19, 1996, page 11). I was surprised to see the comment, "When rigorous scientific trials on laetrile, vitamin C, hydrazine sulfate, chelation therapy, chiropractic, and homeopathy proved them worthless . . ." While I recognize that some of the trials to which he refers fail to demonstrate significant scientific evidence to support the use of a particular approach, that cannot be stated about the application of chiropractic procedures if we are to believe the results of the Agency for Health Care Policy and Research.

This governmental committee, in 1994, issued a bulletin on low back pain and recommended the use of spinal manipulation "as done by chiropractors and others" as a first defense against low back pain. The basis for the decision to recommend spinal manipulation for low back pain was the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies